GlassScriptPhysician profile
Christopher Anton Murphy
NPI 1063131548
$300.50
in general payments reported to CMS, 2019-2025
10 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $121 · 2024: $28.36 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $60.68 | 2023 | Gammatile |
| Medexus Pharma, INC. | $60.68 | 2023 | Gleolan |
| Abbvie INC. | $34.07 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.92 | 2024-2025 | |
| Exelixis INC. | $32.79 | 2025 | Cabometyx |
| Janssen Biotech, INC. | $19.29 | 2025 | Talvey, Darzalex |
| Novocure INC. | $17.99 | 2025 | Optune Gio |
| Syndax Pharmaceuticals, INC. | $14.64 | 2025 | |
| Merck Sharp & Dohme LLC | $13.83 | 2024 | Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $13.61 | 2025 | Fruzaqla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.